BOLT INVESTOR ALERT: Bronstein, Gewirtz and Grossman, LLC Reminds Stockholders of Bolt Biotherapeutics, Inc. to Contact the Firm Today!Accesswire • 08/18/24
ROSEN, RECOGNIZED INVESTOR COUNSEL, Encourages Bolt Biotherapeutics, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action – BOLTGlobeNewsWire • 08/17/24
The Schall Law Firm Seeks Shareholders To Lead Securities Fraud Lawsuit Against Bolt Biotherapeutics IncAccesswire • 08/16/24
BOLT INVESTOR ALERT: Bronstein, Gewirtz and Grossman, LLC Reminds Shareholders of Bolt Biotherapeutics, Inc. to Contact the Firm Today!Accesswire • 08/16/24
Investors Encouraged To Join In The Bolt Biotherapeutics, Inc. Securities Fraud Lawsuit With The Schall Law FirmAccesswire • 08/15/24
BOLT INVESTOR ALERT: Bronstein, Gewirtz and Grossman, LLC Reminds Investors of Bolt Biotherapeutics, Inc. to Contact the Firm Today!Accesswire • 08/15/24
Investors Can Take The Lead In The Bolt Biotherapeutics, Inc. Securities Fraud Lawsuit With The Schall Law FirmAccesswire • 08/14/24
ROSEN, TOP-RANKED INVESTOR COUNSEL, Encourages Bolt Biotherapeutics, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action – BOLTGlobeNewsWire • 08/14/24
BOLT SHAREHOLDER ALERT: Bronstein, Gewirtz and Grossman, LLC Reminds Bolt Biotherapeutics, Inc. Shareholders to Actively Participate in Class Action Lawsuit!Accesswire • 08/14/24
The Schall Law Firm Invites Investors To Lead The Securities Fraud Lawsuit Against Bolt Biotherapeutics IncAccesswire • 08/14/24
Bolt Biotherapeutics Reports Second Quarter 2024 Financial Results and Provides Business UpdateGlobeNewsWire • 08/13/24
BOLT SHAREHOLDER ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that Bolt Biotherapeutics, Inc. Shareholders Have Opportunity to Lead Class Action Lawsuit!Accesswire • 08/13/24
Investors Are Invited To Lead The Securities Fraud Lawsuit Of Bolt Biotherapeutics Inc With The Schall Law FirmAccesswire • 08/13/24
BOLT INVESTOR ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that Bolt Biotherapeutics, Inc. Stockholders Have Opportunity to Lead Class Action Lawsuit!Accesswire • 08/12/24
Investors Can Head The Securities Fraud Lawsuit Of Bolt Biotherapeutics Inc With The Schall Law FirmAccesswire • 08/10/24
ROSEN, A LONGSTANDING LAW FIRM, Encourages Bolt Biotherapeutics, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action – BOLTGlobeNewsWire • 08/09/24
BOLT SHAREHOLDER ALERT: Bronstein, Gewirtz and Grossman, LLC - RECOGNIZED INVESTOR COUNSEL - Reminds Bolt Biotherapeutics, Inc. Shareholders to Lead Class Action Lawsuit!Accesswire • 08/09/24
BOLT Investors Have Opportunity to Lead Bolt Biotherapeutics, Inc. Securities Fraud LawsuitPRNewsWire • 08/08/24
Investors Have The Opportunity To Lead Bolt Biotherapeutics Inc Securities Fraud Lawsuit With The Schall Law FirmAccesswire • 08/08/24
BOLT INVESTOR ALERT: Bronstein, Gewirtz and Grossman, LLC Reminds Bolt Biotherapeutics, Inc. Shareholders to Lead Class Action Lawsuit!Accesswire • 08/08/24
BOLT Investors Are Invited To Take The Lead In The Bolt Biotherapeutics Inc Securities Fraud Case With The Schall Law FirmAccesswire • 08/08/24
BOLT Investors Have The Opportunity To Lead Bolt Biotherapeutics Inc Securities Fraud Lawsuit With The Schall Law FirmAccesswire • 08/06/24
ROSEN, GLOBAL INVESTOR COUNSEL Encourages Bolt Biotherapeutics, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action – BOLTGlobeNewsWire • 08/04/24
BOLT INVESTOR ALERT: Bronstein, Gewirtz and Grossman, LLC Reminds Bolt Biotherapeutics, Inc. Shareholders to Contact the FirmAccesswire • 08/02/24
BOLT Investors Can Lead The Bolt Biotherapeutics Inc. Securities Fraud Lawsuit With The Schall Law FirmAccesswire • 07/30/24
